Meta-Analysishigh evidence

Timing, Translation, and Preparedness: Lessons Learned From COVID-19 Anticoagulation in Noncritically Ill Hospitalized Patients.

Journal of the American College of Cardiology·July 28, 2026·PMID 42523015

Why it matters

For critical care and internal medicine specialists managing COVID-19 inpatients, this analysis confirms a modest benefit of therapeutic-dose anticoagulation on organ support or death without a significant bleeding signal, reinforcing current guideline recommendations. It also underscores systemic delays in evidence translation that can inform preparedness for future health emergencies.

Infographic summary of Timing, Translation, and Preparedness: Lessons Learned From COVID-19 Anticoagulation in Noncritically Ill Hospitalized Patients.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled